The rise of more transparent, “Cost Plus” pharmacy models is stirring debate within the pharmaceutical space as smaller players put pressure on the large PBMs. In January 2022, entrepreneur Mark Cuban ...

Starjemza's inclusion in Cost Plus Drugs' portfolio aims to challenge traditional specialty medication economics and enhance ...

Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable prescription drugs. Starjemza® ...

The massive PBM’s announcement comes as the drug middlemen attempt to lessen regulatory scrutiny. The company also said it will move to a cost-plus reimbursement model for in-network pharmacies.

As both a lawmaker and pharmacist, Abbott brings a “different knowledge” to the legislature and the regulation side of ...

Optum Rx has signaled a shift to a cost-based pharmacy reimbursement model that's intended to have pharmacies pay more for brand-name drugs and less for generics. The model will reduce variation in ...

Navitus announced that cost-plus pricing will now be available through Costco Pharmacy for prescriptions filled at retail and mail order locations. It will be implemented on Jan. 1, 2026. Under the ...

Starting in January, Navitus Health Solutions members will see cost-plus pricing at Costco Pharmacy for select prescriptions. The alternative pharmacy benefit manager (PBM) said the pricing shift will ...

In May, Rite Aid filed for Chapter 11 bankruptcy for the second time in two years, announcing plans and court approval to close almost all of its approximately 1,200 stores nationwide. The ...

"We're excited to partner with Mark Cuban Cost Plus Drugs, a company that shares our commitment to transparency, ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. As I write this, the first quarter of 2025 is quickly drawing to a close. And that means, if ...

LAS VEGAS — Online pharmacy Cost Plus Drugs will be participating in President Donald Trump’s drug price transparency tool, TrumpRx, according to Cost Plus’ founder Mark Cuban. Cuban shared the news ...